Skip to content
Adaptive Biotechnologies Corporation icon

Adaptive Biotechnologies Corporation

ADPTStocksBiotechnologyUnited StatesNasdaqUSD

Price

$27.93

Today

+0.7%

YTD

+72.5%

About

Adaptive Biotechnologies Corporation functions as a biotechnology entity. Specialising in the immune system and disease diagnostics, it operates across the US. The company uses advanced technology to read and translate the genetics of the adaptive immune system, providing essential insights into human health and disease. Operating within the biotechnology industry, Adaptive Biotechnologies works in the field of immune-driven medicine. The company's services extend to diagnostic products that can detect a range of diseases, aiding healthcare providers and patients in proactive disease management. Stay up to date on the share price of ADPT by adding it to your eToro watchlist.

Price chart
Closing price history for ADPT (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.

Open positions

0

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)-68.79
P/S (TTM)14.56
P/B (TTM)31.23
Market cap$4.48B
Cap tierMid-cap
Industry avg P/E-6.15

Profitability

Gross margin72.71%
EBIT margin-11.81%
Net margin-55.61%
ROE-39.58%
ROA-11.23%

Earnings & Revenue

Revenue (TTM)$308.08M
Revenue growth (1Y)+50.1%
EPS (TTM)-$0.41
Free cash flow$-24.03M
Total debt$410.50M

Dividends & Risk

Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)1.68
Employees624
Next earnings4 Nov '26
Trade history

Closed trades

0

Realized return

+0.0%

No stored closed trades exist for this instrument yet.

Adaptive Biotechnologies Corporation (ADPT) | Dirk Kuyken